The current epidemic of primary aldosteronism

Causes and consequences

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Until recently, primary aldosteronism was considered to be a rare cause of identifiable or secondary hypertension. Over the past 10 years, a steadily growing number of reports have claimed that this condition is much more common, present in 5-40% of all hypertensive patients, which translates into many millions of patients. The primary basis for this current epidemic is the application of a relatively simple screening test, the plasma aldosterone to renin ratio (ARR). Despite growing recognition that the ARR is neither sensitive nor specific, its advocates recommend that it should be a routine procedure in evaluation of all hypertensives. Evidence is provided that this recommendation will lead to massive increases in costs, both in money and in morbidity, while providing benefit to only a very small number of patients who would not be aided by continuation of previous diagnostic protocols.

Original languageEnglish (US)
Pages (from-to)863-869
Number of pages7
JournalJournal of Hypertension
Volume22
Issue number5
DOIs
StatePublished - May 2004

Fingerprint

Hyperaldosteronism
Aldosterone
Renin
Hypertension
Morbidity
Costs and Cost Analysis

Keywords

  • Aldosterone to renin ratio
  • Primary aldosteronism
  • Screening tests

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology

Cite this

The current epidemic of primary aldosteronism : Causes and consequences. / Kaplan, Norman M.

In: Journal of Hypertension, Vol. 22, No. 5, 05.2004, p. 863-869.

Research output: Contribution to journalArticle

@article{c01ab1ab68ff43a1b1f5fac2ba28b21e,
title = "The current epidemic of primary aldosteronism: Causes and consequences",
abstract = "Until recently, primary aldosteronism was considered to be a rare cause of identifiable or secondary hypertension. Over the past 10 years, a steadily growing number of reports have claimed that this condition is much more common, present in 5-40{\%} of all hypertensive patients, which translates into many millions of patients. The primary basis for this current epidemic is the application of a relatively simple screening test, the plasma aldosterone to renin ratio (ARR). Despite growing recognition that the ARR is neither sensitive nor specific, its advocates recommend that it should be a routine procedure in evaluation of all hypertensives. Evidence is provided that this recommendation will lead to massive increases in costs, both in money and in morbidity, while providing benefit to only a very small number of patients who would not be aided by continuation of previous diagnostic protocols.",
keywords = "Aldosterone to renin ratio, Primary aldosteronism, Screening tests",
author = "Kaplan, {Norman M}",
year = "2004",
month = "5",
doi = "10.1097/00004872-200405000-00001",
language = "English (US)",
volume = "22",
pages = "863--869",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - The current epidemic of primary aldosteronism

T2 - Causes and consequences

AU - Kaplan, Norman M

PY - 2004/5

Y1 - 2004/5

N2 - Until recently, primary aldosteronism was considered to be a rare cause of identifiable or secondary hypertension. Over the past 10 years, a steadily growing number of reports have claimed that this condition is much more common, present in 5-40% of all hypertensive patients, which translates into many millions of patients. The primary basis for this current epidemic is the application of a relatively simple screening test, the plasma aldosterone to renin ratio (ARR). Despite growing recognition that the ARR is neither sensitive nor specific, its advocates recommend that it should be a routine procedure in evaluation of all hypertensives. Evidence is provided that this recommendation will lead to massive increases in costs, both in money and in morbidity, while providing benefit to only a very small number of patients who would not be aided by continuation of previous diagnostic protocols.

AB - Until recently, primary aldosteronism was considered to be a rare cause of identifiable or secondary hypertension. Over the past 10 years, a steadily growing number of reports have claimed that this condition is much more common, present in 5-40% of all hypertensive patients, which translates into many millions of patients. The primary basis for this current epidemic is the application of a relatively simple screening test, the plasma aldosterone to renin ratio (ARR). Despite growing recognition that the ARR is neither sensitive nor specific, its advocates recommend that it should be a routine procedure in evaluation of all hypertensives. Evidence is provided that this recommendation will lead to massive increases in costs, both in money and in morbidity, while providing benefit to only a very small number of patients who would not be aided by continuation of previous diagnostic protocols.

KW - Aldosterone to renin ratio

KW - Primary aldosteronism

KW - Screening tests

UR - http://www.scopus.com/inward/record.url?scp=2542432149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542432149&partnerID=8YFLogxK

U2 - 10.1097/00004872-200405000-00001

DO - 10.1097/00004872-200405000-00001

M3 - Article

VL - 22

SP - 863

EP - 869

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 5

ER -